Lamotrigine
NDC 62332-419, Lamotrigine, tablet, extended release, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-419
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211821
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-419 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-419-30 | 62332041930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-419-30) |
| 62332-419-91 | 62332041991 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-419-91) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4bd7193f-a81a-4909-90c2-7f324fc6ddfd
Use it
Look up 62332-419 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-419 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-419. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.